Summary | |
---|---|
Symbol | PPM1G |
Name | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
Aliases | PP2CG; PP2Cgamma; PP2C, gamma; protein phosphatase 2C, gamma isoform; protein phosphatase 1G (formerly 2C), ...... |
Chromosomal Location | 2p23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cytoplasm Membrane Lipid-anchor |
Domain |
PF00481 Protein phosphatase 2C |
Function |
- |
Biological Process |
GO:0006470 protein dephosphorylation GO:0007050 cell cycle arrest GO:0016311 dephosphorylation GO:0035970 peptidyl-threonine dephosphorylation GO:0045786 negative regulation of cell cycle |
Molecular Function |
GO:0004721 phosphoprotein phosphatase activity GO:0004722 protein serine/threonine phosphatase activity GO:0016791 phosphatase activity GO:0042578 phosphoric ester hydrolase activity |
Cellular Component | - |
KEGG | - |
Reactome | - |
Summary | |
---|---|
Symbol | PPM1G |
Name | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
Aliases | PP2CG; PP2Cgamma; PP2C, gamma; protein phosphatase 2C, gamma isoform; protein phosphatase 1G (formerly 2C), ...... |
Chromosomal Location | 2p23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between PPM1G and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | PPM1G |
Name | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
Aliases | PP2CG; PP2Cgamma; PP2C, gamma; protein phosphatase 2C, gamma isoform; protein phosphatase 1G (formerly 2C), ...... |
Chromosomal Location | 2p23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of PPM1G in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | PPM1G |
Name | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
Aliases | PP2CG; PP2Cgamma; PP2C, gamma; protein phosphatase 2C, gamma isoform; protein phosphatase 1G (formerly 2C), ...... |
Chromosomal Location | 2p23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of PPM1G in various data sets.
|
Points in the above scatter plot represent the mutation difference of PPM1G in various data sets.
|
Summary | |
---|---|
Symbol | PPM1G |
Name | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
Aliases | PP2CG; PP2Cgamma; PP2C, gamma; protein phosphatase 2C, gamma isoform; protein phosphatase 1G (formerly 2C), ...... |
Chromosomal Location | 2p23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of PPM1G. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | PPM1G |
Name | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
Aliases | PP2CG; PP2Cgamma; PP2C, gamma; protein phosphatase 2C, gamma isoform; protein phosphatase 1G (formerly 2C), ...... |
Chromosomal Location | 2p23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of PPM1G. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by PPM1G. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | PPM1G |
Name | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
Aliases | PP2CG; PP2Cgamma; PP2C, gamma; protein phosphatase 2C, gamma isoform; protein phosphatase 1G (formerly 2C), ...... |
Chromosomal Location | 2p23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of PPM1G. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | PPM1G |
Name | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
Aliases | PP2CG; PP2Cgamma; PP2C, gamma; protein phosphatase 2C, gamma isoform; protein phosphatase 1G (formerly 2C), ...... |
Chromosomal Location | 2p23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of PPM1G expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | PPM1G |
Name | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
Aliases | PP2CG; PP2Cgamma; PP2C, gamma; protein phosphatase 2C, gamma isoform; protein phosphatase 1G (formerly 2C), ...... |
Chromosomal Location | 2p23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between PPM1G and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | PPM1G |
Name | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
Aliases | PP2CG; PP2Cgamma; PP2C, gamma; protein phosphatase 2C, gamma isoform; protein phosphatase 1G (formerly 2C), ...... |
Chromosomal Location | 2p23.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting PPM1G collected from DrugBank database. |
There is no record. |